1. Home
  2. SBFM vs VERO Comparison

SBFM vs VERO Comparison

Compare SBFM & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • VERO
  • Stock Information
  • Founded
  • SBFM 2006
  • VERO N/A
  • Country
  • SBFM United States
  • VERO Canada
  • Employees
  • SBFM N/A
  • VERO N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • VERO Medical/Dental Instruments
  • Sector
  • SBFM Health Care
  • VERO Health Care
  • Exchange
  • SBFM Nasdaq
  • VERO Nasdaq
  • Market Cap
  • SBFM 3.7M
  • VERO 3.1M
  • IPO Year
  • SBFM N/A
  • VERO N/A
  • Fundamental
  • Price
  • SBFM $2.35
  • VERO $0.31
  • Analyst Decision
  • SBFM
  • VERO
  • Analyst Count
  • SBFM 0
  • VERO 0
  • Target Price
  • SBFM N/A
  • VERO N/A
  • AVG Volume (30 Days)
  • SBFM 151.4K
  • VERO 2.3M
  • Earning Date
  • SBFM 11-05-2024
  • VERO 11-13-2024
  • Dividend Yield
  • SBFM N/A
  • VERO N/A
  • EPS Growth
  • SBFM N/A
  • VERO N/A
  • EPS
  • SBFM N/A
  • VERO N/A
  • Revenue
  • SBFM $32,959,491.00
  • VERO $67,200,000.00
  • Revenue This Year
  • SBFM $86.70
  • VERO N/A
  • Revenue Next Year
  • SBFM $126.76
  • VERO $7.56
  • P/E Ratio
  • SBFM N/A
  • VERO N/A
  • Revenue Growth
  • SBFM 61.94
  • VERO N/A
  • 52 Week Low
  • SBFM $2.25
  • VERO $0.28
  • 52 Week High
  • SBFM $638.00
  • VERO $2.22
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 25.54
  • VERO 34.77
  • Support Level
  • SBFM $2.58
  • VERO $0.38
  • Resistance Level
  • SBFM $2.86
  • VERO $0.44
  • Average True Range (ATR)
  • SBFM 0.17
  • VERO 0.07
  • MACD
  • SBFM -0.04
  • VERO -0.01
  • Stochastic Oscillator
  • SBFM 12.67
  • VERO 7.27

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

About VERO Venus Concept Inc.

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Share on Social Networks: